Ocular Pharmacology -II

Slides:



Advertisements
Similar presentations
UPDATE ON DRUGS AND THE EYE 1.LOCAL EFFECTS OF TOPICAL EYE MEDICATION.
Advertisements

Topical glaucoma medication with a teal cap? Prostaglandin analogues – Xalatan® (latanoprost) 0.005% qd – Travatan®(travoprost) 0.004% qd – Lumigan® (bimatoprost)
YAG capsulotomy K.P.SHANTHA SORUBARANI.
Clinicopathologic Case
Paras Guide to Glaucoma
Acute Glaucoma Conditions Acute Eye Conditions Course Dr. Sonya Bennett May 2011.
Ocular Trauma Sandra M. Brown, MD 1 and Yair Morad, MD 2 1 Ophthalmology and Visual Sciences Texas Tech University Health Sciences Center Lubbock, Texas.
Mohd Shafiq Bin Paridin Mohd. Firdaus Bin Jamalullail Nik Mohd Abduh Bin Nik Mhd Nor 4 th Year Medical Student Faculty Of Medicine, Zagazig University.
Uveal Tract Diseases.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 18 Ophthalmic and.
ESSAM OSMAN,FRCS ASSISTANT PROFESSOR,CONSULTANT DEPATMENT OF OPHTHALMOLOGY K.S.U.
Pharmacology of drugs acting on the eye
GLAUCOMA DROPS: RX FOR SUCCESS OR TROUBLE? Marilynn Sultana, MD, FACS Cataract and Eye Consultants of Michigan Warren, MI.
Autonomic Innervation of the Eye Trachte March 4, 2008.
DR: Mahmoud Saeed Lecturer Of Clinical Pharmacy BMC
BiologyMad.com The Retina  Contains photoreceptor cells (rods and cones) and associated interneurones and sensory neurones. BiologyMad.com.
Ocular pharmacology and toxicology Hatem Kalantan, MD Assistant Professor Ophthalmology Dept. College of Medicine King Saud University.
The Canadian Association of Optometrists
Agents Used in the Treatment of Conditions of the Eye
PHARMACOLOGY OF THE EYE
Chapter 103 Drugs for the Eye 1.
Ocular Ischaemic Syndrome Dr Gulrez Ansari Department of Ophthalmology Watford General Hospital 3 rd November 2004.
Sensoric disorders Jiří Slíva, M.D..
Adult Medical-Surgical Nursing Neurology Module: Glaucoma.
Glaucoma Abdulrahman Al-Amri, MD. Glaucoma  Definition & Epidemiology  Anatomy & physiology  POAG  ACG  Secondary glaucoma  Management  Quiz.
Acute and Chronic visual loss By Dr. ABDULMAJID ALSHEHAH Ophthalmology consultant Anterior Segment and Uveitis consultant.
Drugs Used to Treat Glaucoma and Other Eye Disorders Chapter 43 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier.
Nursing care of patient with eye disorders
GLAUCOMA TREATMENT Glaucoma Drug Therapy Purpose: - constrict the pupil -reduce production or increase absorption of aqueous humor DRUGS Prostaglandin.
Dr. Abdullah Al-Amri Ophthalmology Consultant
Chronic Visual Loss. CHRONIC VISUAL LOSS 1. Measure intraocular pressure with a tonometer 2. Evaluate the nerve head 3. Evaluate the clarity of the lens.
GLAUCOMA داء الزرقاء.
CASE III NEOVASCULAR GLAUCOMA. Patient History 68 year old white female. Ocular History: CRAO, Medical history: Diabetes Renal Problems.
Ocular Drug Delivery Srinivasulu reddy. Ocular Drug Delivery Introduction Ophthalmic preparation Applied topically to the cornea, or instilled in the.
SPOT DIAGNOSIS DARINDA ROSA R2.
Dorzolamide A topical Carbonic anhydrase inhibitor. Ampholytic characteristics, hence good corneal penetration (depot effect achieved in cornea). Achieves.
PRIMARY OPEN ANGLE GLAUCOMA PROF.DR.ÖZCAN OCAKOĞLU.
By Pharmacist Salwan Salem. * Is the organ which gives the sense of sight. * Eye allows us to see and interpret the shapes, colors, and dimensions of.
Glaucoma. Introduction  Glaucoma are ocular disorder characterized by changes in the optic nerve head (optic disc) and by loss of visual sensitivity.
(Relates to Chapter 22, “Nursing Management: Visual and Auditory Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier.
OCULAR PHARMACOLOGY. ANTIBIOTICS MECHANISM OF ACTION: By inhibiting DNA gyrase a type 2 topo isomerase and topoisomerase 4, enzymes necessary to separate.
OPTO 4101: Refraction1- lab L01: History taking
Sensory.
Focus on Pharmacology Essentials for Health Professionals
ORBIS International.
CGI & Chemical injuries OF THE EYE
Secondary Glaucoma Dated :
Ocular pharmacology and toxicology
3.04 Functions and disorders of the eye
PHARMACOLOGY OF THE EYE
Challenges to drug delivery to the eye
SECONDARY GLAUCOMAS Dr. Shinisha Paul.
Pharmacology of drugs acting on the eye
Overview of Common Eye Conditions
Drugs for diseases and disorders of eyes
Study of the action of Drugs on Human Eyes Lab-7
Ocular pharmacology and toxicology
Challenges to drug delivery to the eye
Chapter 18 Ophthalmic and Otic Medications
Medical Therapy in congenital glaucoma complication and follow up of patients
COMPLICATIONS OF UVEITIS
PHARMACOLOGY OF THE EYE
THERAPY FOR UVEITIS. THERAPY FOR UVEITIS OBSERVATION For development of complications For change in the appearance / severity/progression.
Study of the action of Drugs on Human Eyes Lab-6
Pharmacology Of Drugs Acting On the Eye
Challenges to drug delivery to the eye
pain management Lecture headlines :
Ophthalmic Emergencies
DR ABDULRAHMAN ALSUGAIHE
Presentation transcript:

Ocular Pharmacology -II Dr. Ajai Agrawal Additional Professor Department of Ophthalmology A.I.I.M.S., Rishikesh

Learning Objectives At the end of this class students shall have a basic understanding of : Therapeutic agents for glaucoma Anti-inflammatory agents Tear substitutes Drugs and biological agents used in Ophthalmic surgery Ocular toxicology

Overview Overview of ocular anatomy & physiology Pharmacodynamics and Pharmacokinetics of ocular therapeutic agents Ocular Routes of Drug Administration Therapeutic & Diagnostic applications of Drugs in Ophthalmology Ophthalmic Effects of Selected Vitamin Deficiencies Systemic Agents with Ocular Side Effects Conclusion

Agents used for treatment of Open angle Glaucoma Prostaglandin analogues Beta receptor antagonists Alpha receptor agonists Carbonic anhydrase inhibitors

Prostaglandin Analogs First- line medical therapy for Glaucoma PGF2α analogs - Good efficacy Once daily application Absence of systemic side effects 1.Latanoprost 2. Travoprost 3.Bimatoprost Facilitate aqueous outflow through uveoscleral outflow pathway

Prostaglandin Analogs Side effects Ocular irritation & pain Blurring of vision Increased iris pigmentation Macular edema

β Adrenergic blockers Nonselective β blockers – Timolol maleate - Levobunolol - Metipranolol - Carteolol β -1 antagonist - Betaxolol

Mechanism of Action of β Blockers Lower IOP by reducing aqueous formation -- Down regulation of adenylylcyclase due to β2 receptor blockade in ciliary epithelium -- Reduction in ocular blood flow

Adverse Effects of Ocular β Adrenergic blockers Stinging, redness & dryness of eye Corneal hypoesthesia Allergic blepharoconjunctivitis Blurred vision Systemic Bronchospasm in asthmatics & COPD patients Bradycardia & accentuation of Heart block Minimization of systemic adverse effects

Alpha Adrenergic agonists Brimonidine (Alpha-2 agonist)(0.1%,0.2%) Usually used as an add on agent Mainly reduces aqueous production Also increases uveoscleral outflow To be used cautiously in children and elderly as it may cause fatigue and drowsiness.

Carbonic anhydrase Inhibitors (CAI) Systemic -Acetazolamide Topical CAI – Dorzolamide , Brinzolamide Inhibits carbonic anhydrase (isoenzyme II) on ciliary body epithelium → Reduces formation of bicarbonate ions → Reduces fluid transport → Reduces aqueous formation → Decrease IOP Use – Only as add on drug to topical β blockers or PG analogs Systemic CAI – Final medication option before resorting to laser or incisional surgical treatment

Carbonic anhydrase Inhibitors (CAI) Side effects Paresthesia Frequent urination GI disturbances Hypokalemia

Topical Miotics Only of historical importance in open angle glaucoma - Ciliary muscle contraction - Increase drainage through trabecular meshwork Drug----Pilocarpine 1,2,4%. Less useful drug – Numerous side effects & three to four times a day dosing

Stepped Medical Approach to Treatment of Open Angle Glaucoma Start monotherapy with Latanoprost or topical β blocker If target I.O.P. not attained, either change over to alternative drug or use both the above concurrently Brimonidine/dorzolamide – Use only when there are contraindications to PG analogs/ β blockers or to supplement their action Oral acetazolamide/Topical miotics – Last resort

Angle closure Glaucoma Hypertonic Mannitol ( 20%) IV infusion 1.5 -2 g/kg 2. Acetazolamide - 0.5 g oral 3. Miotic - Pilocarpine (1-4%) 4. Timolol 0.5 % - instilled 12 hourly. Definitive treatment – Surgical/ Laser iridotomy

Anti-inflammatory Corticosteroid NSAID

stimulus Steroids Phospholipase A2 NSAIDS Lipoxygenases Leukotrienes

Corticosteroids Short acting Hydrocortisone, Cortisone, Prednisolone CLASSIFICATION Short acting Hydrocortisone, Cortisone, Prednisolone Intermediate acting Triamcinolone, Fluprednisolone Long acting Dexamethasone ,Betamethasone

Therapeutic Uses of Topical steroids Significant ocular allergy Anterior uveitis Postoperative inflammation following refractive, corneal & intraocular surgery To reduce potential scarring of surgical site (After Glaucoma filtering surgery ) NEVER GIVE STEROIDS IF YOU ARE SUSPECTING ACTIVE INFECTION

Steroids in ocular conditions…… Systemic steroids & by sub-Tenon’s capsule injection – Posterior Uveitis Intravitreal injection – -- Age-related Macular degeneration (ARMD) -- Diabetic Retinopathy -- Cystoid Macular Edema (CME) Parenteral steroids followed by tapering oral doses – Optic Neuritis

ALLERGIC CONJUNCTIVITIS

SCLERITIS

ANTERIOR UVEITIS

Toxicity of Steroids Posterior subcapsular cataracts Secondary infections Secondary open-angle glaucoma 4. Delayed wound healing “ Soft steroids (e.g., Loteprednol ) reduce the risk of elevated IOP ”

SYSTEMIC side effects of steroids Peptic ulcer Hypertension Increased blood sugar Osteoporosis Mental changes Activation of tuberculosis and other infections

Topical NSAIDs & their Ocular Uses Sr. No. Topical NSAID Ocular Use 1 Flurbiprofen To counter unwanted intraoperative miosis during cataract surgery 2 Ketorolac -Seasonal allergic conjunctivitis -Cystoid Macular Edema (CME ) occuring after cataract surgery 3 Diclofenac -Postoperative inflammation 4 Bromfenac Postoperative pain & inflammation after cataract surgery 5 Nepafenac

Tear Substitutes Hypotonic or isotonic solutions – Eg: Carboxymethylcellulose Polyvinyl alcohol Polyethylene and propylene glycol Indications Ocular irritation in various diseases Dry eye disease

Therapeutic Uses of Tear Substitutes Ocular diseases – Allergic conjunctivitis - Blepharitis - Corneal dystrophies - Chemical Burns Systemic diseases – Sjogren’s syndrome - Rheumatoid arthritis - Vitamin A deficiency - Stevens-Johnson syndrome

Immunosuppressive & Antimitotic Agents Agents commonly used – 1. 5-fluorouracil 2. Mitomycin C Used In Glaucoma surgery, to improve success of filtration surgery by limiting postoperative wound-healing process. In corneal surgery, to reduce risk of scarring after excision of pterygium

Immunomodulatory Agent Topical Cyclosporine – Approved for the treatment of chronic dry eye associated with inflammation -Decreases inflammatory markers in lacrimal gland & increases tear production

Ocular diagnostic drugs Fluorescein dye Available as drops or strips Uses: To stain corneal abrasions applanation tonometry detecting wound leak fluorescein angiography Caution: Stains soft contact lens Fluorescein drops can be contaminated by Pseudomonas sp.

Ocular diagnostic drugs Rose bengal stain Stains devitalized epithelium Uses: severe dry eye, herpetic keratitis

Anaesthetics In Ophthalmic Procedures Proparacaine & tetracaine drops – Uses – Tonometry Gonioscopy Removal of foreign bodies, sutures on conjunctiva and cornea Adverse effects: toxic to corneal epithelium allergic reaction (rarely)

Drugs & Biological Agents Used in Ophthalmic Surgery

Drugs & Biological Agents Use in Ophthalmic Surgery Sr. No. Drugs & Biological Agents Use in Ophthalmic Surgery 1 Povidone iodine (5% solution) To prepare periocular skin & to irrigate cornea, conjunctiva & palpebral fornices 2 Viscoelastic substances (chondroitin sulphate, hydroxypropylmethylcellulose) Maintain spaces & protects surfaces during anterior segment surgery 3 Ophthalmic Glue- Cyanoacrylate tissue adhesive Fibrinogen Glue Corneal ulcerations & Perforations To secure conjunctiva & corneal grafts. 4 Anterior Segment Gases Sulfur Hexafluoride (SF6) Perfluoropropane Reattachment of Descemet’s membrane to stroma of Cornea 5 Vitreous Substitutes Reattachment of retina following Vitrectomy.

Botulinum Toxin Type A FDA approved - Strabismus & Blepharospasm associated with dystonia, facial wrinkles (glabellar lines), axillary hyperhydrosis & spasmodic Torticolis MOA – Prevention of acetyl choline release at neuromascular junction – temporary paralysis of locally injected muscle

Ophthalmic Effects of Selected Vitamin Deficiencies & Zinc Deficiency Effects in Anterior Segment Effects in Posterior Segment Vitamin A Conjunctiva(Bitot’s spot, xerosis) Cornea (Keratomalacia , Punctate keratopathy) Retina(Nyctalopia) Retinal pigment epithelium (hypopigmentation) Vitamin B1 ---- Optic nerve (Visual field defects) Vitamin B6 Cornea(Neovascularization) Retina (Atrophy) Vitamin B12 ------ Vitamin C Lens (? Cataract formation) -------

Ophthalmic Effects of Selected Vitamin Deficiencies & Zinc Deficiency Effects in Anterior Segment Effects in Posterior Segment Vitamin E -------- Retina & retinal pigment epithelium (? Macular degeneration) Folic acid ------- Vein occlusion Vitamin K Conjunctiva (Hemorrhage) Retina (Hemorrhage) Zinc ------

Ocular Toxicology

Toxicology All opthalmic medications – Potentially absorbed into systemic circulation – Undesirable systemic side effects Eg. Timolol (single eye drop) - Death Local toxic effects – Hypersensitivity reactions -- Preservatives in eye drops & contact lens solutions – Benzalkonium chloride – Punctate Keratopathy Thimerosal – Hypersensitivity reactions

Complications of topical administration Mechanical injury from the bottle e.g. corneal abrasion Pigmentation: epinephrine-adrenochrome Ocular damage: e.g. topical anesthetics, benzylkonium Hypersensitivity: e.g. atropine, neomycin, gentamicin Systemic effect: topical phenylephrine can increase BP

Amiodarone A drug for treatment of cardiac arrhythmia Causes optic neuropathy (mild decreased vision, visual field defects, bilateral optic disc swelling) Also causes corneal vortex keratopathy (corneal verticillata) which is whorl-shaped pigmented deposits in the corneal epithelium

Digitalis A drug for treating cardiac failure Causes chromatopsia (objects appear yellow) with overdose

Chloroquines E.g. chloroquine, hydroxychloroquine Used in malaria, rheumatoid arthritis, SLE Cause vortex keratopathy (corneal verticillata) which is usually asymptomatic but can present with glare and photophobia Also cause retinopathy (bull’s eye maculopathy)

Chorpromazine An antipsychotic drug Causes corneal punctate epithelial opacities, lens surface opacities Rarely symptomatic Reversible with drug discontinuation

Thioridazine A psychiatric drug Causes a pigmentary retinopathy after high dosage

Diphenylhydantoin An epilepsy drug Causes dosage-related cerebellar-vestibular effects: Horizontal nystagmus in lateral gaze Diplopia, ophthalmoplegia Vertigo, ataxia Reversible with discontinuation of the drug

Topiramate A drug for epilepsy Causes acute angle-closure glaucoma (acute eye pain, redness, blurred vision, haloes). Treatment is by cycloplegia and topical steroids (rather than iridectomy) with the discontinuation of the drug

HMG-CoA reductase inhibitors (statins) Cholesterol lowering agents E.g. pravastatin, lovastatin, simvastatin, fluvastatin, atorvastatin, rosuvastatin Can cause cataract in high dosages specially if used with erythromycin

Ethambutol An anti-tubercular drug Causes a dose-related optic neuropathy Usually reversible but occasionally permanent visual damage might occur

Systemic Agents with Ocular Side Effects Sr. No. Name of Drug Ocular Side Effect 1. Topiramate Angle Closure Glaucoma 2. Hydroxychloroquine/Chloroquine Chloroquine amblyopia ( Bull’s Eye Maculopathy ) 3. Tamoxifen Crystalline Maculopathy 4. Vigabatrin Progressive & Permanent bilateral concentric visual field constriction 5. Sildenafil/Vardenafil/tadalafil Nonarteritic Ischemic Optic Neuropathy (NAION ) 6. Ethambutol, Chloramphenicol , Rifampin Toxic Optic Neuropathy (Progressive bilateral central scotomas & vision loss ) 7. Ocular Steroids Elevated IOP & Glaucoma 8. Steroids Cataract

Systemic Agents with Ocular Side Effects…….. Sr.No. Name of Drug Ocular Side Effect 9. Rifabutin + Clarithromycin / Fluconazole Iridocyclitis & Hypopyon 10. Isotretinoin Dry eye & meibomian gland dysfunction 11. Amiodarone Drug deposits in cornea ( Cornea verticillata ) 12. Chlorpromazine & Thioridazine Brown pigmentary deposits in the cornea 13. Gold Chrysiasis ( gold deposits in cornea & conjunctiva ) 14. Tetracyclines Yellow discoloration of light-exposed conjunctiva

Visual field constriction Cataract

Thank you